HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Xufen Chen Selected Research

Neoplasms (Cancer)

2/2005Effects of sequential treatments with chemotherapeutic drugs followed by TRAIL on prostate cancer in vitro and in vivo.
9/2003Synergistic interactions of chemotherapeutic drugs and tumor necrosis factor-related apoptosis-inducing ligand/Apo-2 ligand on apoptosis and on regression of breast carcinoma in vivo.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Xufen Chen Research Topics

Disease

2Neoplasms (Cancer)
02/2005 - 09/2003
1Urinary Bladder Neoplasms (Bladder Cancer)
02/2005
1Breast Neoplasms (Breast Cancer)
09/2003

Drug/Important Bio-Agent (IBA)

2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
02/2005 - 09/2003
2LigandsIBA
02/2005 - 09/2003
2Caspase 3 (Caspase-3)IBA
02/2005 - 09/2003
1Etoposide (VP 16)FDA LinkGeneric
02/2005
1Vinblastine (Vinblastine Sulfate)FDA Link
02/2005
1Vincristine (Oncovin)FDA LinkGeneric
02/2005
1CaspasesIBA
02/2005
1Paclitaxel (Taxol)FDA LinkGeneric
02/2005
1Antineoplastic Agents (Antineoplastics)IBA
02/2005
1CamptothecinIBA
02/2005
1Doxorubicin (Adriamycin)FDA LinkGeneric
02/2005
1TNF-Related Apoptosis-Inducing LigandIBA
09/2003

Therapy/Procedure

1Therapeutics
09/2003